Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication.
The article describes the clinical management of a patient referred, with a diagnosis of schizophrenia, who experienced adverse effects associated with an elevated prolactin level. A reflective model was adopted to inform the new learning which emerged from the clinical scenario. It highlights that Mental Health Nurse Supplementary Prescribers need to develop a prescribing value base underpinned by choice in addition to advanced technical skills to manage unhelpful effects of medication.
Jones
M
M
North East Wales NHS Trust, Wrexham, UK. martin.jones@sabp.nhs.uk
Jones
A
A
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002755:Choice Behavior; D006801:Humans; D008297:Male; D009723:Nurse-Patient Relations; D011568:Psychiatric Nursing; D012559:Schizophrenia / Q000188:drug therapy / Q000451:nursing*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents